Click Here to return To Results

 

A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine Neurol 63:261-269,202, Silberstein,S.D.,et al, 2004 See this aricle in Pubmed Article Abstract Frovatriptan given prophylactically for 6 days was effective in reducing the incidence of menstrually associated migraine. More than half of patients who used frovatriptan 2.5 mg BID had no menstrually associated migraine headache during the 6-day perimenstrual period. The findings are consistent with the long duration of action and good tolerability of frovatriptan observe din short-term migraine management.

Related Tags

(click to filter results - removes previous filter) frovatriptan migraine migraine,menses migraine,prophylaxis migraine,treatment of treatment of neurologic disorder triptans

Click Here to return To Results